To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Liver Diseases: Washington and Sunderland West
Thursday 9th May 2024

Asked by: Sharon Hodgson (Labour - Washington and Sunderland West)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to support the detection of liver disease in Washington and Sunderland West constituency.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Northern Cancer Alliance (NCA) is supporting services to enable the early detection of liver disease across the North East and North Cumbria (NENC) Integrated Care Board (ICB), including in the Washington and Sunderland West Constituency. The focus of work has been to support liver services across NENC to invite more than 80% of patients with cirrhosis, a type of liver disease, to monthly ultrasound surveillance. For 2024/25, the NCA has invested just over £200,000 into trusts across NENC to help improve their monitoring systems for cirrhosis patients.

The NENC ICB is also enrolled in a Community Liver Health Check pilot in Newcastle, being delivered by the system’s Hepatitis C Operational Delivery Networks. This will provide FibroScans in one stop community clinics where patients have relevant blood testing, liver ultrasound, and other investigations, as required. The pilot has expanded into North Tyneside and when resources allow, they intend to develop additional clinics across the area.


Written Question
Leukaemia: Research
Thursday 9th May 2024

Asked by: Cat Smith (Labour - Lancaster and Fleetwood)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to improve research into acute myeloid leukaemia.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Department is proud to invest £1.3 billion per year in health research through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was over £121.8 million for 2022/23, and more is spent on cancer than any other disease group.

The Government, through the NIHR, is committed to improving research into the cancers with the poorest survival rates, such as acute myeloid leukaemia, by funding high quality, timely research that leads to improved outcomes for patients and the public, and makes the health and social care system more efficient, effective, and safe. Research evidence is vital for improving treatments and outcomes for people, including those with pancreatic cancer, and other less survivable cancers. The following table shows NIHR research spend on diagnosis, treatment, and diagnosis and treatment of blood cancers, which includes leukaemia, since 2018:

Number of projects

Total awards value

Blood cancer diagnosis

11

£11,900,000

Blood cancer treatment

14

£14,700,000

Blood cancer diagnosis and treatment

4

£7,700,000


In 2023, the Government awarded £2 million to new interdisciplinary research teams tackling hard to treat cancers, via the Medical Research Council’s two-day cancer sandpit strategic funding opportunity, focused on technological innovation for understanding cancers with the poorest survival rates.


The NIHR continues to encourage and welcome applications for research into any aspect of human health, including acute myeloid leukaemia. All applications are assessed for funding by peer review committees. The level of research spend in a particular area is driven by factors including the quality of the proposals, and their scientific potential. All applications for research into pancreatic cancer and other less survivable cancers, made through open competition, have been funded.


Non-Departmental Publication (Statistics)
Advisory Council on the Misuse of Drugs

May. 08 2024

Source Page: Alkyl nitrites: ACMD exemption consideration
Document: (PDF)

Found: .................... ................................ ......... 16 Immunity, viral infections and cancer


Commons Chamber
Oral Answers to Questions - Tue 07 May 2024
HM Treasury

Mentions:
1: Maggie Throup (Con - Erewash) That would not only help to protect more people from one of the leading causes of preventable cancer, - Speech Link
2: Andrew Gwynne (Lab - Denton and Reddish) Many of those campaigning for justice in the contaminated blood scandal will have been encouraged by - Speech Link


Parliamentary Research
Medicines shortages - CBP-9997
May. 01 2024

Found: 2023 5 Case study: Price concessions for atorvastatin Atorvastatin , a medicine used to lower blood


Public Bill Committees
Tobacco and Vapes Bill (Third sitting)
Committee stage:s: 3rd sitting - Wed 01 May 2024
Department of Health and Social Care

Mentions:
1: Preet Kaur Gill (LAB - Birmingham, Edgbaston) Lung cancer is the one that everyone knows about, and 80% of lung cancers are caused by smoking. - Speech Link
2: Andrea Leadsom (Con - South Northamptonshire) vulnerable to recovery and it can be a much harder road to recovery for her, with the risk of infection and blood - Speech Link
3: Caroline Johnson (Con - Sleaford and North Hykeham) are you aware of any research into which chemicals from vaping may be transported from the mother’s blood - Speech Link


Scottish Parliament Debate - Committee
Drug Deaths and Drug Harm - Wed 01 May 2024

Mentions:
1: None We have a huge amount of research and evidence on, for example, cancer treatment and cancer care and - Speech Link
2: None social care outcomes for people who use services—that includes fatal overdoses, hospital admissions, blood-borne - Speech Link


Non-Departmental Publication (News and Communications)
Medicines and Healthcare products Regulatory Agency

Apr. 30 2024

Source Page: MHRA’s AI regulatory strategy ensures patient safety and industry innovation into 2030
Document: AIaMD (PDF)

Found: normally require human skills: identifying abnormalities on cross -sectional imaging to detect lung cancer


Westminster Hall
Glaucoma and Community Optometry - Tue 30 Apr 2024
Department of Health and Social Care

Mentions:
1: Jim Shannon (DUP - Strangford) It is incredible to live in an age when 50% of all cancer patients can survive and people’s eyesight - Speech Link
2: Andrew Gwynne (Lab - Denton and Reddish) condition; being of African, Caribbean or east Asian origin; and having long or short sight, diabetes or blood - Speech Link
3: Andrew Gwynne (Lab - Denton and Reddish) That is particularly important for people with diabetes, glaucoma, high blood pressure and cardiovascular - Speech Link


Westminster Hall
Preventable Sight Loss - Tue 30 Apr 2024
Department of Health and Social Care

Mentions:
1: Margaret Greenwood (Lab - Wirral West) Ophthalmologists have also told me that it is impacting capacity for the treatment of conditions such as cancer - Speech Link
2: Kirsty Blackman (SNP - Aberdeen North) Eye checks can also highlight more serious conditions such as cardiovascular issues, high blood pressure - Speech Link
3: Preet Kaur Gill (LAB - Birmingham, Edgbaston) physiotherapists in some parts of the country, without seeing a GP; in Greater Manchester, where lung cancer - Speech Link
4: Margaret Greenwood (Lab - Wirral West) for example, a road traffic accident; the treatment needed for newborn babies; and the treatment of cancer - Speech Link